Compile Data Set for Download or QSAR
maximum 50k data
Found 23 of ic50 for monomerid = 319995
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  4nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  4nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  4nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  4nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  5nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  5nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  5nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  5nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  5nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2/3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  72nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2(Homo sapiens (Human))
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  72nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2/3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  72nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2(Homo sapiens (Human))
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  72nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2(Homo sapiens (Human))
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  74nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2/3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  74nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2/3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  83nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2(Homo sapiens (Human))
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  251nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetP2X purinoceptor 2/3(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50:  251nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2C9(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2C8(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 1A2(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319995(3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiaz...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent